CSI Market
Sign In | Register

Actavia Life Sciences Inc (RASP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RASP Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Actavia Life Sciences Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2024)
(Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.05
Total Current Assets0.05
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.00
Total Assets0.05
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.50
Derivative Liability, Current DE0.00
Short-term Debt0.21
Other Liabilities, Current0.52
Total Current Liabilities2.23
Total Long-term Debt0.00
Due To Related Partie Current0.00
Total Liabilities2.23
Stockholders' Equity
Common Stock Value0.77
Additional Paid In Capital Common Stock25.95
Retained Earnings / Accumulated Deficit-28.91
Other Equity0.00
Common Stockholder's Equity-2.18
Total Stockholder's Equity-2.18
Liabilities & Stockholder's Equity0.05
4 historic quarters locked

Sign in to unlock the full Actavia Life Sciences Inc balance sheet history.

Sign In Create Free Account

About Actavia Life Sciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-24-045020

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.